PURE Bioscience, Inc. (PURE)
OTCMKTS · Delayed Price · Currency is USD
0.0905
-0.0095 (-9.50%)
Jun 5, 2025, 11:08 AM EDT

Revenue by Product

Fiscal year is August - July.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jul '24 Jul '23 Jul '22 Jul '21 Jul '20 2017 - 2019
Pure Hard Surface
1.86M
Log In
Log In
Log In
Log In
Upgrade
Pure Hard Surface Growth
4.03%
Log In
Log In
Log In
Log In
Upgrade
Silverion
97.00K
Log In
Log In
Log In
Log In
Upgrade
Silverion Growth
14.12%
Log In
Log In
Log In
Log In
Upgrade
Royalty
8.00K
Log In
Log In
Log In
Log In
Upgrade
Royalty Growth
33.33%
Log In
Log In
Log In
Log In
Upgrade
Antimicrobial Products
-
Log In
Log In
Log In
Log In
Upgrade
Antimicrobial Products Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is August - July.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jul '24 Jul '23 Jul '22 Jul '21 Jul '20 2017 - 2019
United States
1.96M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
4.58%
Log In
Log In
Log In
Log In
Upgrade
Foreign
-
Log In
Log In
Log In
Log In
Upgrade